20.01.2021

HPC – Fosfomycin-Trometamol Granulat/Pulver

Anwendungseinschränkungen sowie Streichung der 2 g Dosierung

20.01.2021

Out-of-Stock – COVID-19 – Authorisations for the temporary import and distribution of human medicines – Update

Licences in accordance with art. 22 para. 3 of the COVID 19 Ordinance 3

19.01.2021

DHPC – Tecentriq® (Atezolizumab)

Identifizierung des Risikos schwerer kutaner Nebenwirkungen (Severe Cutaneous Adverse Reactions, SCARs) in Verbindung mit TECENTRIQ®

15.01.2021

Out-of-Stock – Orencia 250 mg, Pulver zur Herstellung eines Infusionslösungskonzentrats

Befristete Bewilligung zum Vertrieb in französischer Aufmachung

12.01.2021

Swissmedic grants authorisation for the COVID-19 vaccine from Moderna

Second COVID-19 vaccine authorised in Switzerland

11.01.2021

Swissmedic warns of the danger of buying vaccines or other medicines online

If you purchase medicines or vaccines from an unregulated source you are putting your health at risk

11.01.2021

Batch recall – Ketalgin, Lösung zum Einnehmen

Rückruf der Chargen 5910/53 und 5910/54 bis auf Stufe Detailhandel

08.01.2021

HPC – Brivex (Brivudin)

Potenziell tödliche Toxizität von Fluoropyrimidinen bei der Anwendung kurz vor, gleichzeitig mit oder innerhalb von 4 Wochen nach Ende der Behandlung mit Brivudin

In focus

Covid-19-Fokus

21.12.2020

Coronavirus disease (COVID-19) Pandemic

Information on the new coronavirus (SARS-CoV-2)

Restricted phone availability – please write to us instead!

Due to the COVID-19 pandemic, Swissmedic is currently receiving more queries than usual. We are therefore unable to receive telephone enquiries. Please submit your questions to us by e-mail (anfragen@swissmedic.ch).

Thank you for bearing with us.

Medical devices
New EU regulations (MDR, IVDR)

Information concerning the new EU-Regulations as well as their implementation in Switzerland.

Direct links


Stay up to date


Incident reporting

Medicines

Reporting undesirable effects


Medical devices

Reporting incidents & FSCAs

Featured


swissmedic-specials_hmv4-teaser

04.12.2018

Therapeutic Products Legislation update

The modifications following the ordinary revision of the TPA and its right of enforcement will enter into force on 1 January 2019

swissmedic-teaser-mep-video1-anim

What are the tasks of Swissmedic in the area of medical devices?

What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.

Medical devices: List of Field Safety Corrective Actions (FSCA) and recalls

Swissmedic monitors all safety measures and recalls for medical devices that are manufactured or marketed in Switzerland.


Swissmedic, Swiss Agency for Therapeutic Products

swissmedic_hauptsitz-hallerstrasse7-bern_03

Swissmedic – for therapeutic products you can trust

Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.

For further information...
https://www.swissmedic.ch/content/swissmedic/en/home.html